Category Archives: Cardiovascular

Ad hoc announcement pursuant to Art. 53 LR  ‘Pure-play’ innovative medicines strategy focused on four therapeutic areas and five technology platforms, which offer potential for consistent growth Mid-term sales guidance upgrade to 5% CAGR (2022-27), with core operating income margin of ~40%+ by 2027, driven by continued strong momentum of key growth drivers   Confidence to […]

MONDAY, Nov. 27, 2023 (HealthDay News) — Filtration of traffic-related air pollution (TRAP) may mitigate its adverse effects on blood pressure, according to a study published online Nov. 28 in the Annals of Internal Medicine. Michael T. Young, M.P.H., Ph.D., from the University of Washington in Seattle, and colleagues conducted a randomized crossover trial involving […]

Schedule regular check-ups with a healthcare provider to monitor cholesterol levels, blood sugar, and overall heart health. Early detection and management of risk factors can significantly reduce the likelihood of heart-related issues. Prioritizing cardiovascular health through lifestyle choices and regular medical check-ups is vital for men. By adopting a heart-healthy lifestyle that includes regular exercise, […]

Former smokers avoid more than half of the excess cardiovascular, cancer, and respiratory mortality associated with current smoking within the first decade after quitting, according to a research letter published online Nov. 27 in JAMA Internal Medicine. Blake Thomson, D.Phil., and Farhad Islami, M.D., Ph.D., from the American Cancer Society in Atlanta, examined the association […]

Medtronic has added a new device, the Penditure Left Atrial Appendage (LAA) Exclusion System, to its cardiac surgery portfolio. The device was designed for the exclusion of the LAA in patients undergoing concomitant heart surgeries, a step intended to help reduce their risk of stroke. It arrives pre-loaded on a single-use delivery system. “The strategic […]

Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced the first patient enrollment in the PEERLESS II study. This prospective, global, multi-center randomized controlled trial (“RCT”) compares the outcomes of intermediate-risk acute pulmonary embolism (“PE”) […]

<div data-thumb="https://scx1.b-cdn.net/csz/news/tmb/2023/dapagliflozin-5-mg-dai-1.jpg" data-src="https://scx2.b-cdn.net/gfx/news/hires/2023/dapagliflozin-5-mg-dai-1.jpg" data-sub-html="Credit: eClinicalMedicine (2023). DOI: 10.1016/j.eclinm.2023.102334″> Credit: eClinicalMedicine (2023). DOI: 10.1016/j.eclinm.2023.102334 The DAPPER study was conducted with the National Cardiovascular Center as the principal investigator, with 294 patients participating from 18 facilities in Japan. In this study, researchers investigated whether dapagliflozin suppresses urinary albumin excretion, a sensitive marker of kidney damage, and whether […]

The U.S. Food and Drug Administration (FDA) has announced that Unomedical A/S is recalling thousands of boxes of its VariSoft Infusion Sets designed to assist with the delivery of insulin to diabetes patients. The FDA considers this a Class I recall, which means using these devices “may cause serious injuries or death.” The VariSoft Infusion […]

La Fundación Colombiana del Corazón y la Sociedad Colombiana de Cardiología, apoyados por Pfizer implementaron el programa educativo “Corazones Responsables en Población Negra”, a través del cual certificaron a más de 350 mujeres de Cali, Buenaventura, Quibdó e Istmina durante seis meses de formación, con talleres educativos y lúdicos para prepararlas como líderes del conocimiento […]